Publications by authors named "P Gierschik"

Claim this Profile
A
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.
Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov, Eugen Tausch, Rashmi Priyadharshini Dheenadayalan, Peter Gierschik

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity.
Jan-Bernd Funcke, Barbara Moepps, Julian Roos, Julia von Schnurbein, Kenneth Verstraete, Peter Gierschik

N Engl J Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.
Julia Zinngrebe, Barbara Moepps, Thomas Monecke, Peter Gierschik, Ferdinand Schlichtig

EMBO Mol Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M Roessner, Peter Gierschik

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncatalytic Bruton's tyrosine kinase activates PLCγ variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.
Martin Wist, Laura Meier, Orit Gutman, Jennifer Haas, Sascha Endres, Peter Gierschik

J Biol Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis